Evidence map›Paper›PMID 42212797›Full record

ReviewmSphere2026

Hidden battles: dissecting host-fungal interactions and immune heterogeneity in infection outcomes.

Rebecca A Drummond

Abstract readReview
In one paragraph

Review in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rebecca A DrummondInstitute of Immunology and Immunotherapy, School of Infection, Inflammation and Immunity, College of Medical and Health Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-5424-7074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections remain a major global human health problem, responsible for billions of infections and millions of deaths each year. Dissecting the immune mechanisms that protect us against these infections is an important step toward developing alternative therapies for patients at risk for fungal diseases, who are typically immunocompromised. Understanding antifungal immune responses is complicated by heterogeneity within host cell populations, as well as in-host adaptation strategies employed by fungi, which may also drive multiple distinct populations during infection. In this article, I discuss our recent discoveries and that of the medical mycology field, which has used creative and interdisciplinary approaches to better define the multiple layers of complexity that influence host-fungal interactions and infection outcomes. Finally, I describe examples where fundamental discovery has translated into new treatment approaches for patients and may represent revolutionary changes for our growing field.

Indexed as

FungiHost-Pathogen InteractionsMycosesAnimalsAntifungal AgentsHumansAntifungal Agentsfungihost-pathogen interactionsimmune responsemeningitismycology

Identifiers

PMID42212797
PMCPMC13317229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.